Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.89M Sell
73,684
-59,512
-45% -$6.5M 0.08% 176
2026
Q1
$11.1M Buy
133,196
+7,665
+6% +$657K 0.1% 158
2025
Q4
$10.7M Sell
125,531
-30,787
-20% -$2.57M 0.14% 134
2025
Q3
$13.1M Buy
156,318
+84,755
+118% +$7.74M 0.17% 116
2025
Q2
$7.25M Buy
71,563
+71,560
+2,385,333% +$7.3M 0.1% 157
2025
Q1
$319 Sell
3
-3
-50% -$311 ﹤0.01% 2105
2024
Q4
$658 Buy
6
+3
+100% +$349 ﹤0.01% 1960
2024
Q3
$435 Hold
3
﹤0.01% 1966
2024
Q2
$438 Hold
3
﹤0.01% 1944
2024
Q1
$429 Hold
3
﹤0.01% 1467
2023
Q4
$281 Hold
3
﹤0.01% 1481
2023
Q3
$265 Hold
3
﹤0.01% 1438
2023
Q2
$338 Buy
3
+2
+200% +$238 ﹤0.01% 1326
2023
Q1
$127 Hold
1
﹤0.01% 1348
2022
Q4
$108 Hold
1
﹤0.01% 1285
2022
Q3
$0 Hold
1
﹤0.01% 1268
2022
Q2
$0 Hold
1
﹤0.01% 1309
2022
Q1
$0 Buy
+1
New +$95 ﹤0.01% 1389

Other funds holding CROX

Clearstead Advisors's CROX Position: Q2 2026 in Review

Clearstead Advisors reduced its Crocs (CROX) stake by 45% in Q2 2026, selling an estimated $6.5M and leaving 73,684 shares worth $8.89M. The position accounts for 0.08% of the portfolio, ranked #176.

Clearstead Advisors first reported a position in CROX in Q1 2022 and has held it in 18 quarters since. The position peaked at $13.1M in Q3 2025. 501 funds tracked by Wall St. Rank hold CROX as of Q2 2026.

  • Clearstead Advisors held 73,684 shares of Crocs worth $8.89M as of Q2 2026.
  • Clearstead Advisors sold 59,512 Crocs shares in Q2 2026, an estimated $6.5M.
  • Crocs made up 0.08% of Clearstead Advisors's portfolio in Q2 2026, its #176 holding.
  • Clearstead Advisors first reported a position in Crocs in Q1 2022 and has held it in 18 quarters since.
  • Clearstead Advisors's Crocs position peaked at $13.1M in Q3 2025.
  • 501 funds tracked by Wall St. Rank held Crocs as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.